ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
급성 췌장염 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에 CAGR은 6.2%를 나타낼 것으로 예측되고 80억 1,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 고령화 동향, 인식 제고 및 조기 진단 노력, 유전적 소인 연구, 치료 방식의 발전 등에 기인할 수 있습니다. 예측 기간의 주요 동향으로는 영양 지원에 대한 주력, 환자 교육 및 인식 프로그램, 표준화된 프로토콜 시행, 재생 치료법 탐구, 연속 모니터링 및 추적 관찰 등이 포함됩니다.
향후 5년간 6.2% 성장이라는 예측은 이전 전망 대비 0.2% 소폭 하락한 수치입니다. 이 하락은 주로 미국과 타국 간 관세 영향 때문입니다. 미국 의료 시스템은 관세 인상으로 캐나다와 네덜란드에서 원산지인 췌장 효소 대체제 및 내시경 역행성 담췌관조영술(ERCP) 장비 비용이 증가함에 따라 치료 공백이 발생할 수 있으며, 이는 환자 예후 악화로 이어질 수 있습니다. 또한 상호 관세 부과와 무역 긴장 및 제한 강화로 인한 전 세계 경제 및 무역에 대한 부정적 영향으로 그 영향이 더욱 광범위하게 나타날 것입니다.
향후 몇 년간 의료비 지출 증가가 급성 췌장염 시장 성장을 촉진할 것으로 예상됩니다. 의료비 지출은 의료 서비스 및 관련 활동 제공에 활용되는 모든 재정적·비재정적 자원을 포함합니다. 만성 질환 유병률 증가, 건강보험 적용 범위 확대, 정신 건강 문제에 대한 인식 제고 등 여러 요인이 의료비 지출 증가에 기여합니다. 급성 췌장염은 괴사성 췌장염, 장기 부전, 감염 등 심각한 합병증을 유발할 수 있으며, 이는 추가 치료, 수술, 장기 입원을 필요로 하여 의료비를 상당하게 증가시킵니다. 예를 들어, 캐나다에 기반을 둔 비영리 기관인 캐나다 보건정보연구소(Canadian Institute for Health Information)는 2023년 총 의료비 지출이 3,440억 달러에 될 것으로 전망했으며, 이는 전년 대비 2.8%의 소폭 증가를 반영한 수치입니다. 따라서 증가하는 의료비 지출은 급성 췌장염 시장 성장을 주도하는 핵심 요인입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 급성 췌장염 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 급성 췌장염 시장 : 성장률 분석
세계의 급성 췌장염 시장 실적 : 규모와 성장(2019-2024년)
세계의 급성 췌장염 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 급성 췌장염 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 급성 췌장염 시장 : 원인별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
담석
알코올
기타 원인
세계의 급성 췌장염 시장 : 치료별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
정맥 내 수액
영양 지원
진통제
내시경 역행성 담췌관조영술(ERCP)
기타 치료법
세계의 급성 췌장염 시장 : 진단별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
화상 검사
임상 검사
세계의 급성 췌장염 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 급성 췌장염 시장, 알코올 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
급성 알코올성 췌장염
폭음 유발성 췌장염
세계의 급성 췌장염 시장, 기타 원인 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
약제성 췌장염
외상성 췌장염
감염증 유발성 췌장염
대사 장애
제7장 지역별 및 국가별 분석
세계의 급성 췌장염 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 급성 췌장염 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
급성 췌장염 시장 : 경쟁 구도
급성 췌장염 시장 : 기업 프로파일
CalciMedica Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
SCM Lifescience Co. Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Samsung Bioepis Co Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Global Neurotech Pharma Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Baxter International Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
B. Braun Melsungen AG
Medtronic plc
Boston Scientific Corporation
Fresenius Kabi AG
Sun BioPharma Inc.
Atox Bio Inc.
D-Pharm Ltd.
Regeneron Pharmaceuticals Inc.
Merck & Co Inc
Olympus Corporation
Pfizer Inc.
Ionis Pharmaceuticals Inc.
Abbott Laboratories
Dynavax Technologies Corporation
GlaxoSmithKline plc
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
급성 췌장염 시장(2029년) : 새로운 기회를 제공하는 국가
급성 췌장염 시장(2029년) : 새로운 기회를 제공하는 부문
급성 췌장염 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Acute pancreatitis is a medical condition characterized by the inflammation and enlargement of the pancreas during a brief period. This condition is commonly caused by either gallstones or excessive alcohol consumption.
The primary causes of acute pancreatitis include gallstones, alcohol consumption, and other factors. Gallstones, which are solidified deposits in the gallbladder, can lead to pain and inflammation of the pancreas when they obstruct the pancreatic duct, resulting in acute pancreatitis. Treatment options for acute pancreatitis typically involve intravenous fluid administration, nutritional support, analgesics, and procedures such as endoscopic retrograde cholangiopancreatography (ERCP). The diagnosis of acute pancreatitis is carried out through imaging tests and laboratory assessments conducted by hospitals, clinics, and other healthcare facilities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The acute pancreatitis market research report is one of a series of new reports from The Business Research Company that provides acute pancreatitis market statistics, including acute pancreatitis industry global market size, regional shares, competitors with a acute pancreatitis market share, detailed acute pancreatitis market segments, market trends, and opportunities, and any further data you may need to thrive in the acute pancreatitis industry. This acute pancreatitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The acute pancreatitis market size has grown strongly in recent years. It will grow from $5.96 billion in 2024 to $6.29 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to high incidence rates, alcohol consumption patterns, gallstone prevalence, tobacco smoking habits, increasing obesity rates.
The acute pancreatitis market size is expected to see strong growth in the next few years. It will grow to $8.01 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to aging population trends, awareness and early diagnosis initiatives, genetic predisposition studies, advancements in treatment modalities. Major trends in the forecast period include focus on nutritional support, patient education and awareness programs, implementation of standardized protocols, exploration of regenerative therapies, continuous monitoring and follow-up.
The forecast of 6.2% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The U.S. healthcare system could experience treatment gaps as tariffs increase costs for pancreatic enzyme replacements and Endoscopic Retrograde Cholangiopancreatography(ERCP) equipment sourced from Canada and the Netherlands, potentially worsening patient outcomes. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rise in healthcare expenditure is anticipated to drive the growth of the acute pancreatitis market in the coming years. Healthcare expenditure encompasses all resources, both financial and non-financial, utilized in delivering health services and related activities. Several factors contribute to the increase in healthcare spending, including the prevalence of chronic diseases, broader health insurance coverage, and heightened awareness of mental health issues. Acute pancreatitis can result in severe complications such as necrotizing pancreatitis, organ failure, and infections, which require additional treatments, surgeries, and extended hospital stays, thereby significantly increasing healthcare costs. For example, the Canadian Institute for Health Information, a nonprofit organization based in Canada, projected that total health expenditure will reach $344 billion in 2023, reflecting a modest growth of 2.8% compared to the previous year. Thus, the rising healthcare expenditure is a key factor propelling the growth of the acute pancreatitis market.
The escalating incidence of obesity is poised to fuel the expansion of the acute pancreatitis market in the foreseeable future. Obesity, characterized by an excessive accumulation of body fat that poses health risks, is a known risk factor for acute pancreatitis. Its increasing global prevalence contributes to a higher incidence of this condition, thereby increasing the demand for related therapies. In March 2022, the World Health Organization reported a staggering figure of approximately 1 billion individuals worldwide-comprising 650 million adults, 340 million adolescents, and 39 million children-who were obese, with this number still on the rise. Additionally, WHO projections suggest that by 2025, 167 million adults and children will face health issues due to being overweight or obese. Thus, the mounting incidence of obesity serves as a key driver for the acute pancreatitis market.
The anticipated rise in gastrointestinal disorders is poised to be a driving factor behind the growth of the acute pancreatitis market in the forthcoming years. These disorders encompass a spectrum of medical issues affecting the gastrointestinal (GI) tract responsible for digestion and nutrient absorption. Conditions such as cholelithiasis, inflammatory bowel disease, and pancreatitis fall under this category, with pancreatitis often linked to or exacerbated by digestive system complications. This inflammation of the pancreas can be triggered by various factors, some of which are associated with the GI tract. For example, data from Crohn's and Colitis UK in March 2022 indicated that in the UK, one in 123 individuals suffers from ulcerative colitis, a type of inflammatory bowel disease known as Crohn's disease, totaling approximately 500,000 inflammatory bowel disease cases in the country. Hence, the increasing prevalence of gastrointestinal disorders is a significant driver fueling growth within the acute pancreatitis market.
Leading companies in the acute pancreatitis market are focusing on developing innovative technologies, such as dry chemistry slide technology, to accurately measure pancreatic lipase levels. This diagnostic method employs a coated slide with dry reagents to conduct chemical reactions for analyzing biological samples, allowing for quick and precise testing without the use of liquid reagents. For example, in June 2024, IDEXX Laboratories Inc., a diagnostics and healthcare innovation firm based in the U.S., launched the catalyst pancreatic lipase test for diagnosing pancreatitis in dogs and cats, which leverages dry chemistry slide technology for accurate pancreatic lipase measurement. The test delivers rapid, quantitative results in less than 10 minutes and integrates smoothly with current workflows, improving diagnostic efficiency. This innovation aims to enhance the early diagnosis and treatment of pancreatitis, a serious condition in pets, and will be further supported by upcoming advancements like the Catalyst SmartQC Control to streamline veterinary diagnostics even more.
In March 2023, CalciMedica Inc., a biopharmaceutical company based in the U.S., merged with Graybug Vision for an undisclosed amount. This merger aims to strengthen the development of CalciMedica's lead product candidate, Auxora, which is intended for treating severe inflammatory diseases, particularly acute pancreatitis, by pooling resources and expertise. Graybug Vision Inc. is also a U.S.-based biopharmaceutical firm that specializes in creating innovative therapies for ocular diseases.
Major companies operating in the acute pancreatitis market include CalciMedica Inc., SCM Lifescience Co. Ltd., Samsung Bioepis Co Ltd., Global Neurotech Pharma Corporation, Baxter International Inc., B. Braun Melsungen AG, Medtronic plc, Boston Scientific Corporation, Fresenius Kabi AG, Sun BioPharma Inc., Atox Bio Inc., D-Pharm Ltd., Regeneron Pharmaceuticals Inc., Merck & Co Inc, Olympus Corporation, Pfizer Inc., Ionis Pharmaceuticals Inc., Abbott Laboratories, Dynavax Technologies Corporation, GlaxoSmithKline plc, AbbVie Inc., Allergan plc, Amgen Inc., AstraZeneca PLC, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Novartis AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Johnson & Johnson
North America was the largest region in the acute pancreatitis market in 2024. The regions covered in the acute pancreatitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the acute pancreatitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The acute pancreatitis market includes revenues earned by entities by providing therapies, medications, and procedures aimed at managing and treating the condition. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Acute Pancreatitis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on acute pancreatitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for acute pancreatitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The acute pancreatitis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Cause: Gallstones; Alcohol; Other Causes
2) By Treatment: Intravenous Fluid; Nutritional Support; Analgesics; Endoscopic Retrograde Cholangiopancreatography (ERCP); Other treatments
3) By Diagnosis: Imaging tests; Laboratory Tests
4) By End Users: Hospitals; Clinics; Other End-Users
Subsegments:
1) By Gallstones: Cholecystitis-Induced Pancreatitis; Choledocholithiasis-Induced Pancreatitis
2) By Alcohol: Acute Alcoholic Pancreatitis; Binge Drinking-Induced Pancreatitis
3) By Other Causes: Medications-Induced Pancreatitis; Trauma-Induced Pancreatitis; Infections-Induced Pancreatitis; Metabolic Disorders
Companies Mentioned: CalciMedica Inc.; SCM Lifescience Co. Ltd.; Samsung Bioepis Co Ltd.; Global Neurotech Pharma Corporation; Baxter International Inc.; B. Braun Melsungen AG; Medtronic plc; Boston Scientific Corporation; Fresenius Kabi AG; Sun BioPharma Inc.; Atox Bio Inc.; D-Pharm Ltd.; Regeneron Pharmaceuticals Inc.; Merck & Co Inc; Olympus Corporation; Pfizer Inc.; Ionis Pharmaceuticals Inc.; Abbott Laboratories; Dynavax Technologies Corporation; GlaxoSmithKline plc; AbbVie Inc.; Allergan plc; Amgen Inc.; AstraZeneca PLC; Boehringer Ingelheim GmbH; Bristol-Myers Squibb Company; Eli Lilly and Company; F. Hoffmann-La Roche AG; Novartis AG; Sanofi SA; Takeda Pharmaceutical Company Limited; Teva Pharmaceutical Industries Ltd.; Johnson & Johnson
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Acute Pancreatitis Market Characteristics
3. Acute Pancreatitis Market Trends And Strategies
4. Acute Pancreatitis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Acute Pancreatitis Growth Analysis And Strategic Analysis Framework
5.1. Global Acute Pancreatitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Acute Pancreatitis Market Growth Rate Analysis
5.4. Global Acute Pancreatitis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Acute Pancreatitis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Acute Pancreatitis Total Addressable Market (TAM)
6. Acute Pancreatitis Market Segmentation
6.1. Global Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gallstones
Alcohol
Other Causes
6.2. Global Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
